<DOC>
	<DOCNO>NCT02818959</DOCNO>
	<brief_summary>The objective study evaluate feasibility , safety effectiveness first generation transfemoral JenaValve Pericardial TAVR System ( formerly name JenaValve TAVI Plus System- Transfemoral ) elderly patient population severe aortic stenosis high risk surgical aortic valve replacement .</brief_summary>
	<brief_title>First Man Study JenaValve TAVI Plus System Transfemoral</brief_title>
	<detailed_description>The study design prospective , multi-center trial conduct 2 center Germany enrol 12 subject . Each patient follow 2 year . The last patient 's follow-up end February 2016 . It plan study end June 2016 . Study endpoint define accordance `` Standardized endpoint definition transcatheter aortic valve implantation clinical trial : consensus report Valve Academic Research Consortium ( VARC-2 ) '' . These endpoint definition combine expertise surgeon , interventionalists , medical cardiologist , clinical trial specialist allow comparison different trial concern effectiveness safety TAVI .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Heart Valve Diseases</mesh_term>
	<criteria>Diagnosed severe native aortic valve stenosis NYHA functional class II high Increased risk surgical aortic valve replacement Comply postoperative followup visit requirement Combined aortic valve disease severe aortic insufficiency Presence moderate mitral insufficiency previous mitral prosthesis Severe pulmonary hypertension Congenital uni bicuspid aortic valve Endocarditis active infection Life expectancy &lt; 12 month Need emergency surgery reason</criteria>
	<gender>All</gender>
	<minimum_age>75 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Aortic Valve Disease</keyword>
	<keyword>Aortic Valve Replacement</keyword>
	<keyword>Transcatheter</keyword>
	<keyword>Transfemoral</keyword>
	<keyword>Aortic Stenosis</keyword>
</DOC>